Phase 4 Hemophilia A With Inhibitor Clinical Trials

3 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–3 of 3 trials

Recruiting

Phase 4

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Hemophilia A With InhibitorHemophilia B With Inhibitor

American Thrombosis and Hemostasis Network55 enrolled21 locationsNCT04647227

Recruiting

Phase 4

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Hemophilia A With Inhibitor

Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05888870

Recruiting

Phase 4

Pharmacokinetic-guided Dosing of Emicizumab

AdultHemophilia A With InhibitorAdolescent+3 more

Kathelijn Fischer95 enrolled8 locationsNCT06320626